Trial site
Ridley-Tree Cancer Center
- 18running trials
- 7closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Pancreatic cancer4 trials
- Melanoma3 trials
- Ovarian cancer3 trials
- Prostate cancer3 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Childhood cancers1 trial
- Chronic lymphocytic leukaemia1 trial
- Endometrial cancer1 trial
- Head and neck cancer1 trial
- Kidney cancer1 trial
- and 4 more
- Phase
- Phase 315 trials
- Phase 25 trials
- Phase 2/34 trials
- Phase 11 trial
- Status
- Recruiting11 trials
- Active, not recruiting7 trials
- Completed5 trials
- Terminated2 trials
- Suspended1 trial
- Lead sponsor
- NRG Oncology9 trials
- SWOG Cancer Research Network4 trials
- Alliance for Clinical Trials in Oncology2 trials
- National Cancer Institute (NCI)2 trials
- Aadi Bioscience, Inc.1 trial
- and 8 more
Running trials
Recruiting
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Recruiting
Recruiting
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Active, not recruiting
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer2 recruiting
- Ovarian cancer2 recruiting
- Pancreatic cancer2 recruiting
- Colorectal cancer1 recruiting
- Gastric and oesophageal cancer1 recruiting
- Kidney cancer1 recruiting
- Meningioma1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Terminated
Niraparib in the Treatment of Patients With Advanced PALB2 Mutated Tumors
Completed
Completed
Completed
UV1 Vaccination Plus Nivolumab and Ipilimumab in Treatment of Melanoma
Completed
Terminated
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026